Jurkat (Human T cell lymphoblast-like cell line) Whole Cell Lysate (ab7899)
Overview
- Product nameJurkat (Human T cell lymphoblast-like cell line) Whole Cell LysateSee all Jurkat lysates ...
- General notesCell line: Jurkat, clone E6-1 (Human acute T cell leukemia) Growth media: RPMI & 10% NCS (Newborn calf serum)
- Tested applicationsWB more details
Properties
- FormLiquid
- Storage instructionsShipped at 4°C. Upon delivery aliquot and store at -20°C or -80°C. Avoid repeated freeze / thaw cycles.
- Storage bufferpH: 6.80
Constituent: 5% Beta mercaptoethanol -
Concentration information loading... - PurityWhole Cell Lysate
- Lysate notes Jurkat cell lysate was prepared by homogenization in modified RIPA buffer (150 mM sodiumchloride, 50 mM Tris-HCl, pH 7.4, 1 mM ethylenediaminetetraacetic acid, 1 mM phenylmethylsulfonyl flouride, 1% Triton X-100, 1% sodium deoxycholic acid, 0.1% sodium dodecylsulfate, 5 µg/ml of aprotinin, 5 µg/ml of leupeptin). Cell debris was removed by centrifugation. Protein concentration was determined with Bio-Rad protein assay. The cell lysate was boiled for 5 min in 1 x SDS sample buffer (50 mM Tris-HCl pH 6.8, 12.5% glycerol, 1% sodium dodecylsulfate, 0.01% bromophenol blue) containing 5% b-mercaptoethanol.
- Research Areas
Applications
Our Abpromise guarantee covers the use of ab7899 in the following tested applications.
The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.
| Application | Notes |
|---|---|
| WB | WB: Use at an assay dependent dilution. Jurkat cell lysate is ready to load on SDS-PAGE for Western blotting, 20 µg per lane is recommended for mini gel. |
References for Jurkat (Human T cell lymphoblast-like cell line) Whole Cell Lysate (ab7899)
This product has been referenced in:
- Berra-Romani R et al. Ca2+ handling is altered when arterial myocytes progress from a contractile to a proliferative phenotype in culture. Am J Physiol Cell Physiol 295:C779-90 (2008). Read more (PubMed: 18596214) »
